International Flavors & Fragrances Inc.'s Stock Analysis

International Flavors & Fragrances Amends Bylaws Effective Immediately

On October 29, 2025, the Board of Directors of International Flavors & Fragrances Inc. approved amended and restated bylaws, which are now effective immediately. The summary provided does not include all details of the amendments, and investors are encouraged to refer to the complete text of the Bylaws attached as Exhibit 3.1 for more information.

The report also notes that it has been signed on behalf of the company in accordance with the Securities Exchange Act of 1934. This amendment to the bylaws may have implications for corporate governance and operational procedures within the company.

Nov 04, 2025 16:06:42

International Flavors & Fragrances Reports Q3 2025 Financial Results

International Flavors & Fragrances (IFF) reported net sales of $2.69 billion for the third quarter of 2025, marking an 8% decrease compared to the same period last year. However, on a currency-neutral basis, sales remained flat, supported by growth in the Scent and Taste segments. Adjusted operating EBITDA for the quarter was $519 million, reflecting a 7% improvement on a comparable basis, primarily due to productivity gains and favorable net pricing. The company reported earnings per share of $0.16 and adjusted EPS of $1.05 per diluted share.

Despite the challenges in the operating environment, IFF reiterated its full-year 2025 financial guidance, expecting sales between $10.6 billion and $10.9 billion, and adjusted operating EBITDA between $2 billion and $2.15 billion. The company anticipates a 1% to 4% growth in comparable currency-neutral sales and a 5% to 10% increase in adjusted operating EBITDA for the year. Additionally, IFF noted that recent foreign exchange rates could negatively impact sales and EBITDA growth by approximately 1% and 3%, respectively, and that the divestiture of Pharma Solutions would also affect overall financial performance for the year.

Nov 04, 2025 16:21:11

Board Changes at International Flavors & Fragrances Announced

International Flavors & Fragrances has announced changes to its Board of Directors, effective October 20, 2025. Mr. Brett Icahn has replaced Mr. Vincent Intrieri as the Icahn Designee director, while Dr. Richard Mulligan has taken the place of Ms. Margarita Paláu-Hernández. Both departing directors stated that their exits were not due to disagreements with the company or its management. The appointments of Mr. Icahn and Dr. Mulligan align with the terms of a Cooperation Agreement with the Icahn Group.

Mr. Icahn, an investor and portfolio manager at Icahn Capital, has extensive experience serving on various boards, while Dr. Mulligan is a distinguished academic and has held significant positions in biotechnology. Both directors qualify as independent under New York Stock Exchange regulations. They will participate in the company's non-employee director compensation arrangements as outlined in the 2024 Proxy Statement. No material transactions involving the company and the new directors have been reported since the beginning of the last fiscal year.

Oct 22, 2025 16:15:48

International Flavors & Fragrances Announces New Accounting Officer

International Flavors & Fragrances Inc. appointed Marc Birenkrant as Controller & Chief Accounting Officer, effective August 10, 2025. Birenkrant has over 30 years of finance and accounting experience, having been with the company since 2008 in various leadership roles. He previously worked at The Wendy’s Company and began his career at Ernst & Young LLP.

Birenkrant replaces Beril Yildiz, who has served in the role since 2022 and will assist in the transition before departing the company on December 31, 2025. Yildiz's departure qualifies for the company’s executive severance policy.

Aug 07, 2025 16:31:06

International Flavors & Fragrances Announces $500M Share Buyback Plan

International Flavors & Fragrances (IFF) reported its financial results for the second quarter of 2025, revealing net sales of $2.76 billion, a 4% decrease from the previous year. However, on a currency-neutral basis, sales increased by 3%, attributed to growth in various segments, including Taste and Health & Biosciences. The company also reported a reduction in leverage to 2.5x and reaffirmed its full-year financial guidance, anticipating sales between $10.6 billion and $10.9 billion and adjusted operating EBITDA between $2 billion and $2.15 billion.

Additionally, IFF's Board of Directors authorized a new share repurchase program allowing for the buyback of up to $500 million in common stock, which will be funded through available cash and operational cash flows. The company is also divesting its soy crush, concentrates, and lecithin business, which generated approximately $240 million in revenue in 2024, as part of its strategy to enhance its portfolio and maximize shareholder value. The transaction is expected to close by the end of 2025.

Aug 05, 2025 16:26:13

New Board Appointments at International Flavors & Fragrances Announced

International Flavors & Fragrances Inc. has appointed Mr. Jesus Mantas and Mr. Paul Fribourg to its board of directors, effective July 29, 2025. Mr. Mantas will join the Audit Committee and Innovation Committee, while Mr. Fribourg will serve on the Transaction Committee. Both individuals bring significant experience from their respective backgrounds, with Mr. Mantas having held leadership roles at IBM Consulting and Mr. Fribourg as Chairman and CEO of Continental Grain Company.

The board has confirmed that both new directors qualify as independent under the New York Stock Exchange rules. There are no arrangements or transactions involving the company that would indicate a material interest from either director. They will participate in the non-employee director compensation arrangements as outlined in the company's 2024 Proxy Statement filed earlier in March 2025.

Jul 30, 2025 16:11:38

IFF Reports Q1 2025 Results with Impairment Impact

IFF announced its financial results for the first quarter of 2025, reporting net sales of $2.84 billion, a 2% decline compared to the previous year. The company experienced a significant loss before taxes of $994 million, largely due to a goodwill impairment of $1.15 billion in its Food Ingredients segment. However, adjusted operating EBITDA for the quarter was $578 million, reflecting a 9% increase year-over-year when adjusted for currency fluctuations. The company's segments, including Taste and Pharma Solutions, showed growth in currency neutral sales, with Taste segment sales rising by 7% on a comparable basis.

Despite the challenges posed by macroeconomic factors, IFF maintained its full-year guidance, anticipating sales between $10.6 billion and $10.9 billion and adjusted operating EBITDA ranging from $2 billion to $2.15 billion. The company noted that foreign exchange rates would negatively impact its sales and EBITDA growth projections. The early divestiture of its Pharma Solutions business is expected to have a significant effect on its financial outlook, with estimates indicating a 7% adverse impact on sales growth for 2025.

May 06, 2025 16:22:24

International Flavors & Fragrances Reports Segment Financial Results

International Flavors & Fragrances Inc. has released its unaudited financial information for the year ending December 31, 2024, reporting total net sales of $11.48 billion. The breakdown of sales by segment shows that Taste generated $2.43 billion, Food Ingredients $3.37 billion, Health & Biosciences $2.20 billion, Scent $2.44 billion, and Pharma Solutions $1.05 billion. The company also reported adjusted operating EBITDA of $2.21 billion with a margin of 19.2% for the full year, reflecting variations across segments. Adjusted operating EBITDA margins ranged from 18.9% for Taste to 26.2% for Health & Biosciences for the full year 2024.

In terms of sales growth, the company reported comparable and currency neutral sales changes for various segments. For the first quarter of 2024 compared to the first quarter of 2023, Taste saw a 5% increase in comparable sales, while Food Ingredients experienced a decline of 6%. Health & Biosciences and Scent reported increases of 4% each, while Pharma Solutions saw a decrease of 7%. Overall, the total sales for the first quarter showed a 1% decline on a reported basis but a 4% increase on a comparable basis. This trend of varying growth rates continued throughout the year with notable performance in the Taste and Health & Biosciences segments.

May 06, 2025 16:15:34

IFF Reports Flat Sales and Decline in Fourth Quarter EPS

International Flavors & Fragrances Inc. (IFF) reported net sales of $11.48 billion for the full year 2024, remaining flat compared to the previous year. However, on a currency-neutral basis, sales increased by 6%, driven by growth in the Scent, Health & Biosciences, and Nourish segments. The company also noted a 16% increase in adjusted operating EBITDA to $2.21 billion, reflecting strong volume growth and productivity gains. Cash flow from operations was reported at $1.07 billion, with free cash flow of $607 million, indicating solid operational performance despite some challenges.

Conversely, the fourth quarter results showed a reported loss before taxes of $115 million and a reported EPS of $(0.18). While net sales rose by 3% year-over-year to $2.77 billion, adjusted operating EBITDA for the quarter was $471 million, marking only a 5% increase compared to the prior year. The Nourish and Health & Biosciences segments experienced mixed results, with the latter showing a decline in adjusted operating EBITDA. Overall, the company faces macroeconomic uncertainties and challenges in specific segments, contributing to a cautious outlook for the upcoming year.

Feb 18, 2025 16:27:47

IFF Reports $2.9 Billion in Third Quarter Sales Growth

IFF reported a net sales increase of 4% in the third quarter of 2024, reaching $2.93 billion, with significant growth across its business segments, particularly in Health & Biosciences and Scent. Adjusted operating EBITDA improved by 16% compared to the previous year, driven by volume growth and productivity enhancements. The company also reported a 17% increase in adjusted earnings per share, which was positively impacted by strong profit performance and lower interest expenses, despite some adverse foreign exchange effects.

On the downside, the Scent segment experienced flat reported sales, and the overall foreign exchange impact is expected to adversely affect sales growth by approximately 3%. Additionally, while the company is increasing its full-year financial guidance, it has noted potential challenges such as inflationary pressures and geopolitical developments that could impact their operations and profitability. The adjusted operating EBITDA margin was slightly lower than the previous year, indicating some pressure on profitability despite overall sales growth.

Nov 05, 2024 16:30:50